Question

Difficulty: MediumInterpreting Imaging Results

During a routine ambulatory clinic visit, evaluation of a male patient in his late sixties reveals a 4-week history of progressive, painless jaundice accompanied by acholic stools, dark urine, and an unintentional 6-kg (13-lb) weight loss. His physical examination is notable for scleral icterus and a palpably enlarged, non-tender gallbladder (Courvoisier sign). Laboratory analysis demonstrates a marked elevation in total bilirubin (14.2 mg/dL) and alkaline phosphatase (720 U/L), with normal aminotransferase levels. The clinical picture is highly suspicious for a malignant extrahepatic biliary obstruction.

Arrange the following diagnostic imaging and procedural modalities in the correct step-wise sequence for evaluating this patient, where the interpretation of each study directly dictates the progression to the next step, ultimately leading to definitive tissue diagnosis and therapeutic palliation.

  1. 1Transabdominal ultrasonography of the right upper quadrant
  2. 2Multiphasic contrast-enhanced computed tomography (CT) of the abdomen
  3. 3Endoscopic ultrasonography (EUS) with fine-needle aspiration
  4. 4Endoscopic retrograde cholangiopancreatography (ERCP) with stent placement

Answer

The correct sequence is: Transabdominal ultrasonography, followed by Multiphasic contrast-enhanced CT of the abdomen, then Endoscopic ultrasonography (EUS) with fine-needle aspiration, and finally Endoscopic retrograde cholangiopancreatography (ERCP) with stent placement.
The evaluation of suspected malignant biliary obstruction requires a disciplined, step-wise sequence. Transabdominal ultrasound must be utilized first to confirm the presence of extrahepatic biliary dilation. A multiphasic CT follows to localize the tumor and assess for both resectability and distant metastases. EUS is then utilized for precise local staging and to obtain a definitive biopsy. Finally, ERCP is employed for therapeutic stenting to decompress the biliary tree.

Step-by-Step Solution

1
Determine the optimal initial diagnostic test for evaluating new-onset painless jaundice.
Transabdominal ultrasonography is selected as the first step.
It is the standard, non-invasive screening tool to confirm biliary dilation and reliably differentiate between medical (intrahepatic) and surgical (extrahepatic) causes of jaundice.
2
Select the appropriate imaging modality for tumor staging based on the initial ultrasound findings.
Multiphasic contrast-enhanced CT of the abdomen is selected as the second step.
Once extrahepatic dilation is confirmed without gallstones, a high-resolution CT provides excellent anatomical detail to locate the suspected mass (e.g., in the pancreatic head), evaluate major vascular invasion, and check for liver metastases.
3
Choose the modality required for definitive tissue diagnosis and precise local staging.
Endoscopic ultrasonography (EUS) with fine-needle aspiration is selected as the third step.
EUS allows for high-resolution imaging of the periampullary region and facilitates targeted, safe biopsy of the mass to confirm malignancy prior to considering surgical resection.
4
Identify the procedural step necessary for symptomatic and therapeutic management.
Endoscopic retrograde cholangiopancreatography (ERCP) with stent placement is selected as the final step.
ERCP provides palliation by stenting the obstructed bile duct, relieving jaundice and intractable pruritus. It is typically performed after diagnostic imaging and staging are complete to avoid causing pancreatitis or altering the staging scans.

Key Concept

The step-wise diagnostic evaluation of painless jaundice (suspected malignant biliary obstruction) relies on progressing sequentially from non-invasive screening (ultrasound) to cross-sectional staging (CT), followed by localized tissue sampling (EUS), and ultimately therapeutic intervention (ERCP).
Rate this question